Ads
related to: REGN- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Search results
Truist Financial Corp Sells 8,062 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 13 hours agoTruist Financial Corp reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.4% in the fourth ...
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell...
Morningstar· 7 days agoOral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demonstrating restoration in children with profound genetic hearing loss Additional presentations ...
TD Cowen lifts Regeneron stock PT to $1,030 despite recent pullback By Investing.com
Investing.com· 5 days agoOn Wednesday, TD (TSX:TD) Cowen showed confidence in Regeneron Pharmaceuticals Inc (NASDAQ:REGN),...
Regeneron and Mammoth Biosciences team up on gene editing By Investing.com
Investing.com· 4 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) and Mammoth Biosciences have announced a...
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 at TD Cowen
ETF DAILY NEWS· 4 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lifted by TD Cowen from $1,020.00 to $1,030.00 in a research report issued ...
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Zacks via Yahoo Finance· 5 days agoToday's Research Daily features new research reports on 16 major stocks, including Danaher...
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday...
Zacks via Yahoo Finance· 4 days agoStocks recently featured in the blog include: Danaher Corp. DHR,Regeneron Pharmaceuticals, Inc....
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 4 days agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...
Regeneron Pharmaceuticals, Inc. [NASDAQ: REGN] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 4 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regeneron Pharmaceuticals, ...
11 Oversold Growth Stocks to Buy Right Now
Insider Monkey via Yahoo Finance· 22 hours agoIn this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip our analysis of the recent trends and market activity,...
